Price $6.40 |
Market Cap
99M
|
Sector Health Care |
Div. Growth
316.70%
|
|
P/E
37.6
|
P/B
2.74
|
P/S
0.45
|
Dividend %
1.90%
|
|
P/CF
69.7
|
P/FCF
44.7
|
Op. Cash Flow
6.8K
|
FCF
0.1
|
|
Op. Margin
2.00%
|
Net Margin
1.20%
|
ROE
7.70%
|
ROI
8.10%
|
|
ROA
3.80%
|
EPS Growth
-8.30%
|
Current Ratio
2.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Journey Medical Corp (DERM) | $4.40 | - | - | 43.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.07 | - | - | 5M | Strong Buy |
| Omnicell Inc (OMCL) | $33.79 | - | - | 1.32B | Strong Buy |
| Evogene Ltd (EVGN) | $0.69 | - | - | 22.7M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $21.64 | - | - | 1.19B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
